Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype. - Wikidata - wikimedia - TriplyDB

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

http://www.wikidata.org/entity/Q33419367

about

Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case report.Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma.A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.Harnessing Solute Carrier Transporters for Precision Oncology.PharmGKB summary: very important pharmacogene information for ABCG2.Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma.

P2860

Q33438859-F33D1FB7-7004-4958-BBFE-9F8863EFFECF Q33440354-60DEF1E1-8ADD-47D4-9106-1473A511051A Q38720430-22E7ADD0-F36B-432B-B74A-FFEFE14EFBAB Q39204754-2666885F-B413-4313-BE0B-32D2B4DCDA68 Q46018199-5D86D037-44BB-4870-9C17-4B18BE346680 Q54119194-F9A541CA-E94C-49C3-AC73-3EC81F21A937

P2860

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

http://www.wikidata.org/entity/Q33419367

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@ast

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@en

type

label

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@ast

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@en

prefLabel

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@ast

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@en

P1433

Q33419367-79E3B55B-803B-44C8-AD75-EE8BB0F8E0FB

P1476

Q33419367-DF700DCE-BDA8-48D4-A251-D085E7FAB9D5

P2093

Q33419367-027A6E42-98E6-478D-9301-C812D098FDEB

Q33419367-128EA883-9DDA-448D-99E0-AE0606A16146

Q33419367-23CA9719-F922-4C02-8443-F60F5864321E

Q33419367-49E2C115-CDBA-4314-86AE-4121227F5CF7

Q33419367-6D90E0ED-FF83-4A1A-8AD1-F854F0E741C6

Q33419367-7DF011FF-837F-4A1B-84E4-815330C69193

Q33419367-C0BA4FB2-4141-4A1C-8124-0CF10EF1B0B5

Q33419367-C9845A6A-DD2E-4B1C-8507-CCD2FD8E67E3

Q33419367-D697D224-8ECD-47C9-A8BD-3D568886EFEC

P2860

Q33419367-01C41303-2BC8-4BC5-82DA-704CDC917A41

Q33419367-1579F1A8-590D-4941-951E-E780C11B3ED5

Q33419367-1E31757D-ABE8-4F0C-9A03-ABE520348835

Q33419367-20D3EC1A-7FA1-4BCA-B02A-AC6E72DBBBA9

Q33419367-3086FBD4-7F59-462E-942B-8D7287942CE1

Q33419367-40DE7C73-4222-4109-8531-17DD1A87E281

Q33419367-492E16FB-1413-4D99-AC01-A2B1E0A1164A

Q33419367-70D01EE5-786F-474F-AA4C-F7B7203DD6C2

Q33419367-736F8BEB-E349-4EA2-819B-9E46E20E1D95

Q33419367-91061261-99A1-45E8-8F86-307F689DB5BB

P2888

Q33419367-BF2BC1D1-70BE-4C27-9E70-65C45F57AE80

P304

Q33419367-F267DCA2-7104-4E8C-8A13-21224D23411B

P31

Q33419367-D3BC1E7D-8F48-48C7-B60E-BE03E5E639F9

P356

Q33419367-D73E53B0-83F5-4BEA-88C3-98C39FE1E5AD

P407

Q33419367-015C0C87-5380-42CE-BC38-5168B5E6D567

P478

Q33419367-D6424136-B657-46F1-8C7A-73ABF68A645E

P50

Q33419367-4E2988AE-E607-4703-A53F-634C8369335C

P577

Q33419367-7E736BFC-25D9-4A1A-AB7E-60A389FC9540

P5875

Q33419367-3B338834-9A2B-4AC9-A945-6C1DD0701F08

P6179

Q33419367-6DB8FCA6-D59C-4D3D-AAB9-45FD0ED9CEF6

P698

Q33419367-19848BFB-720C-4721-8B2F-464E2432D008

P932

Q33419367-E97064E1-81A6-43DC-A466-9674C8A0EC67

P356

1471-2407-14-964

P1433

P1476

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

@en

P2093

Chiyo K Imamura

http://www.w3.org/2001/XMLSchema#string

Koichi Suyama

http://www.w3.org/2001/XMLSchema#string

Koya Fukunaga

http://www.w3.org/2001/XMLSchema#string

Taisei Mushiroda

http://www.w3.org/2001/XMLSchema#string

Toshikazu Okaneya

http://www.w3.org/2001/XMLSchema#string

Toshimi Takano

http://www.w3.org/2001/XMLSchema#string

Yoshihiko Katsuyama

http://www.w3.org/2001/XMLSchema#string

Yuji Miura

http://www.w3.org/2001/XMLSchema#string

Yusuke Tanigawara

http://www.w3.org/2001/XMLSchema#string

P2860

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition.

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.

Treatment of a GIST patient with modified dose of sunitinib by measurement of plasma drug concentrations.

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients.

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinib.

Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients.

P2888

1471-2407-14-964

P304

964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-964

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269773410

http://www.w3.org/2001/XMLSchema#string

P6179

1035870559

http://www.w3.org/2001/XMLSchema#string

P698

25515134

http://www.w3.org/2001/XMLSchema#string

P932

4301945

http://www.w3.org/2001/XMLSchema#string